SEARCH

SEARCH BY CITATION

References

  • Akira, S., T. Hirano, T. Taga, and T. Kishimoto. 1990. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4:28602867.
  • Baouz, S., J. Giron-Michel, B. Azzarone, M. Giuliani, F. Cagnoni, S. Olsson, et al. 2005. Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of α-SMA and NF-kappaB. Int. Immunol. 17:14731481.
  • Calverley, P. M., J. A. Anderson, B. Celli, G. T. Ferguson, C. Jenkins, P. W. Jones, et al. 2007. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 356:775789.
  • Casasnovas, J. M., and T. A. Springer. 1994. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J. Virol. 68:58825889.
  • Condit, R. C. 2006. Principles of Virology. in D. M. Knipe and P. M. Howley, eds. Fields virology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
  • Edwards, M. R., M. W. Johnson, and S. L. Johnston. 2006. Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 34:616624.
  • Edwards, M. R., J. Haas, R. A. Jr Panettieri, M. Johnson, and S. L. Johnston. 2007. Corticosteroids and β2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct cis-acting elements. J. Biol. Chem. 282:1536615375.
  • Farmer, P., and J. Pugin. 2000. β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway. Am. J. Physiol. 279:L675L682.
  • Fiorucci, S., E. Antonelli, E. Distrutti, P. Del Soldato, R. J. Flower, M. J. Clark, et al. 2002. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc. Natl. Acad. Sci. USA 99:1577015775.
  • Fragaki, K., C. Kileztky, C. Trentesaux, J. M. Zahm, O. Bajolet, M. Johnson, et al. 2006. Downregulation by a long-acting β2-adrenergic receptor agonist and corticosteroid of Staphylococcus aureus-induced airway inflammatory mediator production. Am. J. Physiol. 291:L11L18.
  • Fukuchi, Y., A. Nagai, K. Seyama, M. Nishimura, K. Hirata, K. Kubo, et al. 2005. Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol. Treat. Respir. Med. 4:447455.
  • Gekle, M., O. K. Serrano, K. Drumm, S. Mildenberger, R. Freudinger, B. Gassner, et al. 2002. NHE3 serves as a molecular tool for cAMP-mediated regulation of receptor-mediated endocytosis. Am. J. Physiol. 283:F549F558.
  • Gerlo, S., R. Kooijman, I. M. Beck, K. Kolmus, A. Spooren, and G. Haegeman. 2011. Cyclic AMP: a selective modulator of NF-κB action. Cell. Mol. Life Sci. 68:38233841.
  • Greve, J. M., G. Davis, A. M. Meyer, C. P. Forte, S. C. Yost, C. W. Marlor, et al. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839847.
  • Grunberg, K., and P. J. Sterk. 1999. Rhinovirus infections: induction and modulation of airways inflammation in asthma. Clin. Exp. Allergy 29(Suppl. 2):6573.
  • Gu, F., F. Aniento, R. G. Parton, and J. Gruenberg. 1997. Functional dissection of COP-I subunits in the biogenesis of multivesicular endosomes. J. Cell Biol. 139:11831195.
  • Hozawa, S., Y. Haruta, M. Terada, and M. Yamakido. 2009. Effects of addition of beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma. Allergol. Int. 58:509518.
  • Izeboud, C. A., K. H. Hoebe, A. F. Grootendorst, S. M. Nijmeijer, A. S. van Miert, R. R. Witkamp, et al. 2004. Endotoxin-induced liver damage in rats is minimized by β2-adrenoceptor stimulation. Inflamm. Res. 53:9399.
  • Johnson, M. 1991. Salmeterol: a novel drug for the treatment of asthma. Agents Actions (Suppl.) 34:7995.
  • Johnston, S. L., P. K. Pattemore, G. Sanderson, S. Smith, F. Lampe, L. Josephs, et al. 1995. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br. Med. J. 310:12251229.
  • Kanehara, M., A. Yokoyama, Y. Tomoda, N. Shiota, H. Iwamoto, N. Ishikawa, et al. 2008. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. 21:874878.
  • Kaur, M., N. S. Holden, S. M. Wilson, M. B. Sukkar, K. F. Chung, P. J. Barnes, et al. 2008. Effects of β2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am. J. Physiol. 295:L505L514.
  • Kubo, S., I. Matsubara, M. Yamasaki, S. Kasamatsu, E. Koshinaka, H. Kato, et al. 1980. Pharmacological studies of 1-(2-chloro-4-hydroxyphenyl)-t-butylaminoethanol (Hoku-81), a new bronchodilator. Arzneim.-Forsch./ Drug Res. 30:12721278.
  • Marshansky, V., and P. Vinay. 1996. Proton gradient formation in early endosomes from proximal tubes. Biochim. Biophys. Acta 1284:171180.
  • Mellman, I., R. Fuchs, and A. Helenius. 1986. Acidification of the endocytic and exocytic pathways. Ann. Rev. Biochem. 55:663700.
  • Morin, D., R. Sapena, J. P. Tillement, and S. Urien. 2000. Evidence for different interactions between β1- and β2-adrenoceptor subtypes with adenylate cyclase in the rat brain: a concentration-response study using forskolin. Pharamacol. Res. 41:435443.
  • Nass, R., and R. Rao. 1998. Novel localization of a Na+/H+ exchanger in a late endosomal compartment of yeast. Implications for vacuole biogenesis. J. Biol. Chem. 273:2105421060.
  • Nolan, T., R. E. Hands, and S. A. Bustin. 2006. Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 1:15591582.
  • Numazaki, Y., T. Oshima, A. Ohmi, A. Tanaka, Y. Oizumi, S. Komatsu, et al. 1987. A microplate methods for isolation of viruses from infants and children with acute respiratory infections. Microbiol. Immunol. 31:10851095.
  • Oddera, S., M. Silvestri, S. Lantero, O. Sacco, and G. A. Rossi. 1998. Downregulation of the expression of intercellular adhesion molecule (ICAM)-1 on bronchial epithelial cells by fenoterol, a β2-adrenoceptor agonist. J. Asthma 35:401408.
  • Pan, N. Y., W. S. Hui, G. L. Tipoe, G. W. Taylor, R. Y. Leung, W. K. Lam, et al. 2006. Inhibition of pyocyanin-potenciated IL-8 release by steroids in bronchial epithelial cells. Respir. Med. 100:16141622.
  • Papi, A., and S. L. Johnston. 1999. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-κB and GATA transcription factors. J. Biol. Chem. 274:3004130051.
  • Pauwels, R. A., C. G. Lofdahl, D. S. Postma, A. E. Tattersfield, P. O'Byne, P. J. Barnes, et al. 1997. Effects of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337:14051411.
  • Pérez, L., and L. Carrasco. 1993. Entry of poliovirus into cells does not require a low-pH step. J. Virol. 67:45434548.
  • Pizzichini, M. M. M., E. Pizzichini, A. Efthimiadis, A. J. Chauhan, S. L. Johnston, P. Hussack, et al. 1998. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am. J. Respir. Crit. Care Med. 158:11781184.
  • Riise, G. C., S. Larsson, C. G. Lofdahl, and B. A. Andersson. 1994. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur. Respir. J. 7:16731677.
  • Rogers, D. F., and P. J. Barnes. 2006. Treatment of airway mucus hypersecretion. Ann. Med. 38:116125.
  • Ruff, F., J. F. Zander, Y. Edoute, M. C. Santais, N. A. Flavahan, T. J. Verbeuren, et al. 1988. Beta-2 adrenergic responses to tulobuterol in airway smooth muscle, vascular smooth muscle and adrenergic nerves. J. Pharmacol. Exp. Ther. 244:173180.
  • Seemungal, T., R. Harper-Owen, A. Bhowmik, D. J. Jeffries, and J. A. Wedzicha. 2000. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur. Respir. J. 16:677683.
  • Silvestri, M., L. Fregonese, F. Sabatini, G. Dasic, and G. A. Rossi. 2001. Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur. Respir. J. 18:139145.
  • Skevaki, C. L., I. Christodoulou, I. S. Spyridaki, I. Tiniakou, V. Georgiou, P. Xepapadaki, et al. 2009. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin. Exp. Allergy 39:17001710.
  • Subauste, M. C., D. B. Jacoby, S. M. Richards, and D. Proud. 1995. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 96:549557.
  • Suzuki, T., M. Yamaya, K. Sekizawa, N. Yamada, K. Nakayama, S. Ishizuka, et al. 2000. Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Physiol. 278:L560L571.
  • Suzuki, T., M. Yamaya, K. Sekizawa, M. Hosoda, N. Yamada, S. Ishizuka, et al. 2001. Bafilomycin A1 inhibits rhinovirus infection in cultured human tracheal epithelial cells: effects on endosomal pH and ICAM-1 production. Am. J. Physiol. 280:L1115L1127.
  • Suzuki, T., M. Yamaya, K. Sekizawa, M. Hosoda, N. Yamada, S. Ishizuka, et al. 2002. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Respir. Crit. Care Med. 165:11131118.
  • Turner, R. B., and R. B. Couch. 2006. Rhinoviruses. in D. M. Knipe and P. M. Howley, eds. Fields virology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
  • Yamaya, M., H. Nishimura, Y. Hatachi, M. Yoshida, H. Fujiwara, M. Asada, et al. 2011. Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Eur. J. Pharmacol. 650:431444.
  • Yamaya, M., H. Nishimura, Y. Hatachi, H. Yasuda, X. Deng, T. Sasaki, et al. 2012. Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells. Eur. Respir. J. 40:122132.
  • Yasui, K., N. Kobayashi, T. Yamazaki, K. Agematsu, S. Matsuzaki, S. Nakata, et al. 2006. Differential effects of short-acting beta2-agonists on human granulocyte functions. Int. Arch. Allergy Immunol. 139:18.
  • Yoshida, N., M. Muraguchi, M. Kamata, K. Ikezono, and T. Mori. 2009. Procaterol potentiates the anti-inflammatory activity of budesonide on eosinophil adhesion to lung fibroblasts. Int. Arch. Allergy Immunol. 150:352358.
  • Zhu, Z., W. Tang, A. Ray, Y. Wu, O. Einarsson, M. L. Landry, et al. 1996. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κB-dependent transcriptional activation. J. Clin. Invest. 97:421430.